top of page

CHO-K1/Human GPR17(long form) Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0236A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


GPR17 is an orphan receptor belonging to the class A G protein-coupled receptor (GPCR) family. It is primarily expressed in the central nervous system and immune system, where it participates in the development and functional regulation of glial cells. This receptor acts as a sensor for focal myelination damage and contributes to the repair of demyelinated plaques caused by inflammatory processes. As a result, GPR17 is regarded as a potential therapeutic target for promoting remyelination in neurodegenerative diseases such as multiple sclerosis.

 

Screeningbio’s CHO-K1/Human GPR17 Gq cell line overexpress GPR17 receptor and is designed to detect increases in intracellular Calcium flux signal in response to agonist stimulation of the receptor. Molecular Devices Calcium 6 kit can be used to detect the signal. 

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

GPR17

Accession Number

NM_005291 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human GPR17 Agonist Assay. CHO-K1/Human GPR17 cells were treated with the reference agonist . The assay was run based on FLIPR Calcium 6 Assay protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Human GPR17 Agonist Assay. CHO-K1/Human GPR17 cells were treated with the reference agonist . The assay was run based on FLIPR Calcium 6 Assay protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


GPR17 is an orphan receptor belonging to the class A G protein-coupled receptor (GPCR) family. It is primarily expressed in the central nervous system and immune system, where it participates in the development and functional regulation of glial cells.


This receptor acts as a sensor for focal myelination damage and contributes to the repair of demyelinated plaques caused by inflammatory processes. As a result, GPR17 is regarded as a potential therapeutic target for promoting remyelination in neurodegenerative diseases such as multiple sclerosis.


Product Documentation



bottom of page